上海交通大学学报(医学版)

• 综述 • 上一篇    下一篇

11β-羟基类固醇脱氢酶与代谢综合征的相关性

阮莉莉1,2,邹朝春1   

  1. 1.浙江大学  医学院附属儿童医院内分泌科, 杭州 310003; 2.杭州师范大学附属医院, 杭州 310015
  • 出版日期:2014-06-28 发布日期:2014-06-30
  • 通讯作者: 邹朝春, 电子信箱: zou108cc@yahoo.com。
  • 作者简介:阮莉莉(1970—), 女, 副主任医师, 学士; 电子信箱: ruanlili2013@126.com。
  • 基金资助:

    浙江省重点科技创新团队自主立项项目(2010R50045)

Correlation between 11β-hydroxysteroid dehydrogenase and metabolic syndrome

RUAN Li-li1,2, ZOU Chao-chun1   

  1. 1.Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; 2.Department of Pediatrics, the Second People's Hospital, Hangzhou 310015, China
  • Online:2014-06-28 Published:2014-06-30
  • Supported by:

    Zhejiang province Science and Technology Innovation Team Focused on Independent Projects,2010R50045

摘要:

代谢综合征(MetS)是多种代谢成分异常聚集的病理状态,是导致心血管疾病和糖尿病的危险因素。糖皮质激素失调是MetS的重要特征,11β-羟基类固醇脱氢酶(11β-HSD)在体内主要负责活性糖皮质激素向其无活性前体转换,调节局部糖皮质激素浓度。11β-HSD参与了包括胰岛素抵抗、肥胖、2型糖尿病及高血压在内的MetS的病理生理环节,11β-HSD抑制剂在MetS中的应用将为治疗MetS提供新的途径。

关键词: 代谢综合征, 11β-羟基类固醇脱氢酶, 心血管疾病, 糖尿病, 11β-羟基类固醇脱氢酶抑制剂

Abstract:

Metabolic syndrome (MetS) is a pathological condition of disorders of several metabolic components and a risk factor of causing cardiovascular diseases and diabetes. Dysregulation of glucocorticoid is an important feature of MetS. 11β-hydroxysteroid dehydrogenase (11β-HSD) of the body mainly converts the active glucocorticoid to its inactive precursor and regulates the concentration of local glucocorticoid. 11β-HSD involves pathophysiologic processes of MetS such as insulin resistance, obesity, type 2 diabetes, and hypertension. The application of 11β-HSD1 inhibitors may provide new methods for treating MetS.

Key words: metabolic syndrome, 11β-hydroxysteroid dehydrogenases, cardiovascular diseases, diabete, 11β-hydroxysteroid dehydrogenases inhibitors